These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36030752)

  • 1. Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma.
    Schauer AP; Sykes C; Cottrell ML; Imaz A; Podzamczer D; Kashuba AD
    J Pharm Biomed Anal; 2022 Oct; 220():115010. PubMed ID: 36030752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
    Courlet P; Alves Saldanha S; Cavassini M; Marzolini C; Choong E; Csajka C; Günthard HF; André P; Buclin T; Desfontaine V; Decosterd LA
    J Mass Spectrom; 2020 Jun; 55(6):e4506. PubMed ID: 32160389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantification of five antiretrovirals in human tissues using ultra-high performance liquid chromatography-tandem mass spectrometry methods for therapeutic drug monitoring at the sites of action.
    West RE; Oberly PJ; Saylor AJ; Riddler SA; Nolin TD; Devanathan AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124164. PubMed ID: 38823149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the multiplexed quantification of etravirine, maraviroc, raltegravir, and rilpivirine in human plasma and tissue.
    Parsons TL; Marzinke MA
    J Pharm Biomed Anal; 2016 Nov; 131():333-344. PubMed ID: 27632783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive HPLC-MS/MS method for the determination of dolutegravir in human plasma.
    Bennetto-Hood C; Tabolt G; Savina P; Acosta EP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():225-32. PubMed ID: 24361860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of etravirine, maraviroc and raltegravir in pigtail macaque plasma, vaginal secretions and vaginal tissue using a LC-MS/MS assay.
    Blakney AK; Jiang Y; Whittington D; Woodrow KA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1025():110-8. PubMed ID: 27236000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry.
    Yamada E; Takagi R; Sudo K; Kato S
    J Pharm Biomed Anal; 2015 Oct; 114():390-7. PubMed ID: 26112927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an LC-MS/MS assay for the quantification of dolutegravir extracted from human hair.
    Sykes C; Blake K; White N; Schauer AP; Guzman BB; Cottrell ML; Tamraz B; Kashuba ADM
    Anal Bioanal Chem; 2018 Nov; 410(29):7773-7781. PubMed ID: 30280227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
    Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
    Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of raltegravir, dolutegravir and elvitegravir concentrations in human plasma and cerebrospinal fluid samples.
    Tsuchiya K; Ohuchi M; Yamane N; Aikawa H; Gatanaga H; Oka S; Hamada A
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28762239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine.
    Fayet A; Béguin A; Zanolari B; Cruchon S; Guignard N; Telenti A; Cavassini M; Günthard HF; Buclin T; Biollaz J; Rochat B; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1057-69. PubMed ID: 19332396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study.
    Moreira FL; Marques MP; Duarte G; Lanchote VL
    J Pharm Biomed Anal; 2020 Jan; 177():112838. PubMed ID: 31525573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile.
    Tsiang M; Jones GS; Goldsmith J; Mulato A; Hansen D; Kan E; Tsai L; Bam RA; Stepan G; Stray KM; Niedziela-Majka A; Yant SR; Yu H; Kukolj G; Cihlar T; Lazerwith SE; White KL; Jin H
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7086-7097. PubMed ID: 27645238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of doravirine in human plasma using liquid-liquid extraction and HPLC-MS/MS.
    Desai R; Roadcap B; Goykhman D; Woolf E
    Bioanalysis; 2019 Aug; 11(16):1495-1508. PubMed ID: 31502859
    [No Abstract]   [Full Text] [Related]  

  • 15. A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
    Aouri M; Calmy A; Hirschel B; Telenti A; Buclin T; Cavassini M; Rauch A; Decosterd LA
    J Mass Spectrom; 2013 May; 48(5):616-25. PubMed ID: 23674286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring.
    West RE; Oberly PJ; Riddler SA; Nolin TD; Devanathan AS
    J Pharm Biomed Anal; 2024 Mar; 240():115932. PubMed ID: 38198884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology.
    Djerada Z; Feliu C; Tournois C; Vautier D; Binet L; Robinet A; Marty H; Gozalo C; Lamiable D; Millart H
    J Pharm Biomed Anal; 2013 Dec; 86():100-11. PubMed ID: 23995753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
    Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
    J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry--evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization of a labile ester-containing drug.
    Zeng J; Onthank D; Crane P; Unger S; Zheng N; Pasas-Farmer S; Arnold M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):77-84. PubMed ID: 17280881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a simple and rapid method to determine the unbound fraction of dolutegravir, raltegravir and darunavir in human plasma using ultrafiltration and LC-MS/MS.
    Zheng Y; Lui G; Boujaafar S; Aboura R; Bouazza N; Foissac F; Treluyer JM; Benaboud S; Hirt D; Gana I
    J Pharm Biomed Anal; 2021 Mar; 196():113923. PubMed ID: 33571728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.